Thymalfasin for Injection - Effective Influenza Vaccination Adjuvant
ProcurenetShort description
Thymalfasin for Injection is a potent influenza vaccination adjuvant used for adults. Beneficial for immunocompromised individuals, it is injected subcutaneously or intramuscularly.
- Indication: Catapults the effectiveness of influenza vaccinations in challenged immune systems.
- Administration: 1 vial, twice a week, for four weeks starting at first vaccination. Repeat dosage from the eighth to twelfth week.
- Dosage: Comes as a 1.6mg lyophilized powder to be reconstituted with 1 ml water. Administer immediately after reconstitution.
- Production: Monthly capacity of 50,000 vials, principally distributed in North America, Central/South America, Europe, Asia, and Middle East.
Note: Not recommended for use in children and adolescents due to limited data on efficacy and safety.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Introducing Thymalfasin for Injection, a potent influenza vaccination adjuvant specially designed for immunocompromised adults. Thymalfasin, a synthetic thymic peptide, is renowned for its immunostimulant properties which enhances the effectiveness of influenza vaccinations.
Therapeutic Indication:
- Thymalfasin for Injection is exclusively developed for adults, specifically those with compromised immune systems. It serves as an influential adjuvant for influenza vaccination, bolstering the body's immunity and effectively fighting against influenza-caused ailments.
Posology and Method of Administration:
- For optimal results, administer one vial of Thymalfasin subcutaneously or intramuscularly twice a week for four weeks, starting from the time of the first vaccination.
- The treatment must be repeated with identically planned dosage from the eighth (second vaccination) to the twelfth week.
- The lyophilized powder must be reconstituted with 1 ml of Water for Injections. Please note, the solution should be administered immediately after reconstitution for maximum effectiveness.
Dosage Forms and Strengths:
- The product comes in injection form containing 1.6 mg of Thymalfasin as a lyophilized powder in a single-dose vial for reconstitution.
Important info:
- As there are limited data about the use of Thymalfasin in children and adolescents, this product is not recommended for use in these age groups.
- Each JITIDE pack includes an ampoule of 1 mL of solvent (Water for Injection) and a vial of white to off-white lyophilized powder with 1.6 mg of the active substance, Thymalfasin.
